Clarion, Janea B.

HRN: 27-51-60  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/14/2025
08/21/2025
IVT
60 Mg
Q24
Neonatal Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: